MELINTA THERAPEUTICS, INC. /NEW/
DelistedCIK 1461993fmd_0C7G837AGYJ7V56JCAPM9CT86GManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Sep 30, 2019, 40 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 8 | 15 | 27 | 0 | 34 | 96 |
| Cost of revenue | – | – | – | – | – | – | – | 0 | 0 | 41 |
| Gross profit | – | – | – | – | – | – | – | 0 | 34 | 55 |
| Research and development | – | 15 | 17 | 17 | 41 | 63 | 63 | 50 | 49 | 55 |
| Selling, general and administrative | – | – | – | – | – | – | 14 | 19 | 63 | 133 |
| Total operating expenses | – | 19 | 21 | 23 | 51 | 75 | 77 | 69 | 113 | 255 |
| Operating income | – | (19) | (21) | (23) | (43) | (59) | (77) | (69) | (79) | (158) |
| Interest expense | – | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 43 |
| Interest and investment income | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other non-operating income (expense) | – | (1) | (1) | (1) | (2) | (2) | (1) | (2) | (5) | (26) |
| Income before taxes | (19) | (20) | (21) | (24) | – | – | – | – | – | – |
| Income tax expense | – | – | – | – | – | – | – | – | (0) | (0) |
| Net income | – | – | (21) | (24) | (45) | (62) | (79) | (74) | (59) | (157) |
| Net income to common shareholders | – | (23) | (25) | (25) | (45) | (62) | (95) | (95) | (78) | (157) |